(Q51912518)

17 April 2018

title

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. (English)

1 reference

17 April 2018

author

David E. Neal

5

1 reference

17 April 2018

Tim Peters

8

1 reference

17 April 2018

Jenny L Donovan

4

Jenny L Donovan

1 reference

17 April 2018

Freddie Hamdy

6

Freddie C Hamdy

1 reference

17 April 2018

Steven Edward Oliver

2

Steven E Oliver

1 reference

17 April 2018

Lucy Brindle

1

Lucy A Brindle

1 reference

17 April 2018

Daniel Dedman

3

Daniel Dedman

1 reference

17 April 2018

author name string

Janet A Lane

7

1 reference

17 April 2018

publication date

1 October 2006

1 reference

17 April 2018

published in

BJU International

1 reference

17 April 2018

volume

98

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

777-782

1 reference

17 April 2018

Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Short-term effects of population-based screening for prostate cancer on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Scoring the short form ICSmaleSF questionnaire. International Continence Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Sexual dysfunction in men with lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Normative data for the HADS from a large non-clinical sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

EuroQol: the current state of play

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Development and validation of the PCQ: A questionnaire to measure the psychological consequences of screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

The psychological impact of mammographic screening. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06401.X

10.1111/J.1464-410X.2006.06401.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018